Literature DB >> 28725073

Which Regimens Should Be Used and Which Rejected for the Treatment of Helicobacter pylori?

Sotirios D Georgopoulos1, Elias Xirouchakis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28725073     DOI： 10.1038/ajg.2017.90

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  9 in total

Review 1.  Systematic review with meta-analysis: 10- or 14-day sequential therapy vs. 14-day triple therapy in the first line treatment of Helicobacter pylori infection.

Authors:  J-M Liou; C-C Chen; Y-C Lee; C-Y Chang; J-Y Wu; M-J Bair; J-T Lin; M-J Chen; M-S Wu
Journal:  Aliment Pharmacol Ther       Date:  2015-12-15       Impact factor: 8.171

Review 2.  The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults.

Authors:  Carlo A Fallone; Naoki Chiba; Sander Veldhuyzen van Zanten; Lori Fischbach; Javier P Gisbert; Richard H Hunt; Nicola L Jones; Craig Render; Grigorios I Leontiadis; Paul Moayyedi; John K Marshall
Journal:  Gastroenterology       Date:  2016-04-19       Impact factor: 22.682

3.  Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.

Authors:  P Malfertheiner; F Megraud; C A O'Morain; J P Gisbert; E J Kuipers; A T Axon; F Bazzoli; A Gasbarrini; J Atherton; D Y Graham; R Hunt; P Moayyedi; T Rokkas; M Rugge; M Selgrad; S Suerbaum; K Sugano; E M El-Omar
Journal:  Gut       Date:  2016-10-05       Impact factor: 23.059

4.  ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.

Authors:  William D Chey; Grigorios I Leontiadis; Colin W Howden; Steven F Moss
Journal:  Am J Gastroenterol       Date:  2017-01-10       Impact factor: 10.864

5.  Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.

Authors:  Jyh-Ming Liou; Yu-Jen Fang; Chieh-Chang Chen; Ming-Jong Bair; Chi-Yang Chang; Yi-Chia Lee; Mei-Jyh Chen; Chien-Chuan Chen; Cheng-Hao Tseng; Yao-Chun Hsu; Ji-Yuh Lee; Tsung-Hua Yang; Jiing-Chyuan Luo; Chun-Chao Chang; Chi-Yi Chen; Po-Yueh Chen; Chia-Tung Shun; Wen-Feng Hsu; Wen-Hao Hu; Yen-Nien Chen; Bor-Shyang Sheu; Jaw-Town Lin; Jeng-Yih Wu; Emad M El-Omar; Ming-Shiang Wu
Journal:  Lancet       Date:  2016-10-18       Impact factor: 79.321

6.  Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area.

Authors:  Sotirios D Georgopoulos; Elias Xirouchakis; Beatriz Martinez-Gonzalez; Dionyssios N Sgouras; Charikleia Spiliadi; Andreas F Mentis; Fotini Laoudi
Journal:  Helicobacter       Date:  2013-05-29       Impact factor: 5.753

7.  Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area.

Authors:  Sotirios D Georgopoulos; Elias Xirouchakis; Beatrice Martinez-Gonzales; Evanthia Zampeli; Elias Grivas; Charikleia Spiliadi; Maria Sotiropoulou; Kalliopi Petraki; Kostantinos Zografos; Fotini Laoudi; Dionysios Sgouras; Andreas Mentis; Panagiotis Kasapidis; Spyros Michopoulos
Journal:  Eur J Intern Med       Date:  2016-04-28       Impact factor: 4.487

Review 8.  Systematic review with meta-analysis: the efficacy of levofloxacin triple therapy as the first- or second-line treatments of Helicobacter pylori infection.

Authors:  P-Y Chen; M-S Wu; C-Y Chen; M-J Bair; C-K Chou; J-T Lin; J-M Liou
Journal:  Aliment Pharmacol Ther       Date:  2016-06-30       Impact factor: 8.171

Review 9.  First-line Helicobacter pylori eradication therapies in countries with high and low clarithromycin resistance: a systematic review and network meta-analysis.

Authors:  Yee Hui Yeo; Sz-Iuan Shiu; Hsiu J Ho; Biyao Zou; Jaw-Town Lin; Ming-Shiang Wu; Jyh-Ming Liou; Chun-Ying Wu
Journal:  Gut       Date:  2016-09-26       Impact factor: 23.059
  9 in total
  3 in total

1.  Response to Georgopoulos et al.

Authors:  William D Chey; Grigorios I Leontiadis; Colin W Howden; Steven F Moss
Journal:  Am J Gastroenterol       Date:  2017-07       Impact factor: 10.864

2.  Hybrid therapy as first-line regimen for Helicobacter pylori eradication in a high clarithromycin resistance area: a prospective open-label trial.

Authors:  Sotirios D Georgopoulos; Vasilios Papastergiou; Beatriz Martinez-Gonzalez; Elias Xirouchakis; Ioannis Familias; Dionysis Sgouras; Andreas Mentis; Stylianos Karatapanis
Journal:  Ann Gastroenterol       Date:  2017-12-15

3.  Hellenic consensus on Helicobacter pylori infection.

Authors:  Sotirios D Georgopoulos; Spyridon Michopoulos; Theodoros Rokkas; Pericles Apostolopoulos; Evangelos Giamarellos; Dimitrios Kamberoglou; Andreas Mentis; Konstantinos Triantafyllou
Journal:  Ann Gastroenterol       Date:  2020-01-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.